Skip to main content
UniHealth

Doctor search

Samantha Nicole Balakrishnan, NP

Nurse Practitioner · Stanford

NPI 1881977718

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Samantha Nicole Balakrishnan’s office at (650) 723-4000 to ask if they take your plan before you enroll.

State licence records

2 licences

  • Washington ARNP.AP.60282025-NPAdvanced Registered Nurse Practitioner License · since 2012 · expires 2028-11-13
    ActiveNo board action on this licenceCheck it with the state
  • Washington RN.RN.00160851Registered Nurse License · since 2005 · expires 2027-11-13
    ActiveNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$11,033

Medicare paid this office $11,033 for 40 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)27$6,960$142
Long return visit (40+ min)11$1,329$111
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or13$807$25
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's17$369$13

Who their Medicare patients are

40 Original Medicare patients in 2024. Average age 70 · Women 50% · Also on Medicaid 33% · Health risk score 2.73. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 70% · Cancer 43% · Stroke 35%.

The office billed $72,204, Medicare allowed $14,143 and paid $11,033; for 156 services of 5 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202440156702.73$72,204$11,033
202351201692.11$89,226$12,142
202256104672.20$66,824$8,827
20212225681.85$14,963$2,687
20201112711.51$5,217$765
201975174631.35$22,822$12,622
201855103611.39$18,861$7,551
20174085611.58$12,401$6,430
20164492601.21$11,284$6,021

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Long return visit (40+ min)38$7,606$107
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or31$2,786$25

2022: 2 services

Original Medicare services billed in 2022
Long return visit (40+ min)38$5,883$103
Extended patient service without direct patient contact, first hour15$1,347$84

2021: 1 service

Original Medicare services billed in 2021
Long return visit (40+ min)13$1,784$127

2019: 2 services

Original Medicare services billed in 2019
Long return visit (40+ min)32$6,149$92
Return visit (30+ min)43$4,750$60

2018: 2 services

Original Medicare services billed in 2018
Return visit (30+ min)39$4,162$67
Long return visit (40+ min)19$2,243$83

2017: 2 services

Original Medicare services billed in 2017
Return visit (30+ min)27$3,236$69
Long return visit (40+ min)13$2,325$89

2016: 1 service

Original Medicare services billed in 2016
Return visit (30+ min)40$5,307$68

Drugs they prescribed that Part D paid

$291,995

Pharmacies billed $291,995 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (13 of 440) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

424 generic and fewer than 11 brand-name prescriptions · $291,995 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Welireg13$166,044$12,773
Everolimus16$98,942$6,184
Aprepitant13$6,175$475
Lacosamide42$5,010$119
Levetiracetam72$4,297$60
See all 13 drugs
Every Part D drug this clinician prescribed
Welireg13$166,044$12,773
Everolimus16$98,942$6,184
Aprepitant13$6,175$475
Lacosamide42$5,010$119
Levetiracetam72$4,297$60
Duloxetine12$1,439$120
Dexamethasone43$789$18
Gabapentin23$518$23
Modafinil15$406$27
Lamotrigine15$346$23
Ondansetron15$185$12
Famotidine12$156$13
Pantoprazole13$102$8

Year by year

Part D prescribing by year
2024440983% (13)None$291,995
2023349944% (14)None$313,706
202229678NoneNone$85,571
202136986NoneNone$53,025
202019767None8%$33,577
201930559None14%$53,202
201822550None9%$24,889
201719738NoneNone$38,723
201620346None12%$25,512
2014201360% (12)None$205
201312NoneNone0%$104

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 12 drugs

Part D drugs prescribed in 2023
Welireg11$249,330$22,666
Levetiracetam50$3,730$75
Lacosamide19$2,962$156
Dexamethasone22$650$30
Gabapentin22$533$24
Modafinil15$372$25
Duloxetine11$296$27
Ondansetron15$202$13
Lamotrigine16$167$10
Pantoprazole17$156$9
Amlodipine Besylate13$91$7
Hydrocodone-Acetaminophen13$53$4

2022: 9 drugs

Part D drugs prescribed in 2022
Levetiracetam48$4,285$89
Memantine25$1,089$44
Dexamethasone16$404$25
Citalopram Hbr11$341$31
Lamotrigine20$307$15
Ondansetron15$293$20
Gabapentin13$105$8
Amlodipine Besylate22$99$5
Zolpidem11$42$4

2021: 10 drugs

Part D drugs prescribed in 2021
Vimpat21$39,665$1,889
Levetiracetam68$5,028$74
Dexamethasone33$993$30
Lamotrigine29$525$18
Duloxetine14$405$29
Citalopram Hbr29$352$12
Ondansetron21$268$13
Gabapentin12$106$9
Lorazepam15$47$3
Zolpidem12$45$4

2020: 6 drugs

Part D drugs prescribed in 2020
Vimpat11$20,404$1,855
Levetiracetam46$2,392$52
Lamotrigine17$325$19
Dexamethasone12$279$23
Citalopram Hbr13$193$15
Ondansetron14$169$12

2019: 8 drugs

Part D drugs prescribed in 2019
Gleostine16$21,603$1,350
Eliquis13$5,659$435
Levetiracetam52$2,563$49
Dapsone13$1,331$102
Dexamethasone41$1,171$29
Ondansetron28$513$18
Methylphenidate11$280$25
Sulfamethoxazole-Trimethoprim31$269$9

2018: 4 drugs

Part D drugs prescribed in 2018
Levetiracetam55$963$18
Dexamethasone19$561$30
Ondansetron33$506$15
Sulfamethoxazole-Trimethoprim11$117$11

2017: 3 drugs

Part D drugs prescribed in 2017
Methylphenidate13$1,047$81
Levetiracetam35$560$16
Ondansetron12$99$8

2016: 5 drugs

Part D drugs prescribed in 2016
Gleostine16$5,737$359
Dexamethasone22$610$28
Methylphenidate11$592$54
Sulfamethoxazole-Trimethoprim50$249$5
Levetiracetam12$207$17

Money from drug and device companies

$240 in 2025

Industry payments by year
202522None$240
202444None$414
202378None$858
202244None$453
202124None$367

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Argenx USVyvgart$122
1 payment
  • Meals for Vyvgart · 2025-05-14 · $122
Amarin PharmaVascepa$118
1 payment
  • Meals for Vascepa · 2025-03-14 · $118
See all 2 published payments
Every published payment
Argenx USMeals · 2025-05-14Vyvgart$122
Amarin PharmaMeals · 2025-03-14Vascepa$118
See earlier years (2024, 2023, 2022, 2021)

2024: $414

Payments by company in 2024
Axsome TherapeuticsSunosi$125
1 payment
  • Meals for Sunosi · 2024-05-08 · $125
GenzymeDupixent$106
1 payment
  • Meals for Dupixent · 2024-01-11 · $106
Abbott LaboratoriesMitraclip$105
1 payment
  • Meals for Mitraclip · 2024-06-10 · $105
Evofem BiosciencesNone$78
1 payment
  • Meals · 2024-03-13 · $78

2023: $858

Payments by company in 2023
Myriad Genetic LaboratoriesPrecisetumor$129
2 payments
  • Meals for Precisetumor · 2023-07-19 · $61
  • Meals for Precisetumor · 2023-03-02 · $68
Janssen PharmaceuticalsXarelto$128
1 payment
  • Meals for Xarelto · 2023-05-11 · $128
ItiCaplyta$126
1 payment
  • Meals for Caplyta · 2023-02-08 · $126
Gilead SciencesEpclusa$125
1 payment
  • Meals for Epclusa · 2023-09-13 · $125
Exact SciencesCologuard Collection Kit$124
1 payment
  • Meals for Cologuard Collection Kit · 2023-10-11 · $124
Sage TherapeuticsNone$118
1 payment
  • Meals · 2023-05-17 · $118
ACADIA PharmaceuticalsNuplazid$109
1 payment
  • Meals for Nuplazid · 2023-10-18 · $109

2022: $453

Payments by company in 2022
NovocureOptune$134
1 payment
  • Meals for Optune · 2022-11-17 · $134
AmgenRepatha$125
1 payment
  • Meals for Repatha · 2022-08-10 · $125
AbbvieVraylar$105
1 payment
  • Meals for Vraylar · 2022-06-08 · $105
ScynexisNone$88
1 payment
  • Meals · 2022-04-21 · $88

2021: $367

Payments by company in 2021
NovocureOptune$269
3 payments
  • Meals for Optune · 2021-11-19 · $71
  • Meals · 2021-11-15 · $82
  • Meals for Optune · 2021-10-20 · $116
Gilead SciencesEpclusa$98
1 payment
  • Meals for Epclusa · 2021-10-13 · $98

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1881977718
Licence
CA 95013703, MN CNP3551, OH COA.13314-NP, OH RN.380019-COA1, WA AP60282025, WA RN00160851Washington ARNP.AP.60282025-NP: ActiveWashington RN.RN.00160851: Active
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 163W00000X (163W00000X); Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 363LA2200X (363LA2200X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2011-09-27
NPI last updated
2025-12-30
NPI record certified
2025-12-30

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 200 1st St Sw, Rochester, MN, 55905